Literature DB >> 21120565

Retrospective survey on the off-label use of posaconazole in pediatric hematology patients.

S Cesaro, G M Milano, F Aversa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21120565     DOI： 10.1007/s10096-010-1123-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  3 in total

Review 1.  Update on antifungal agents for paediatric patients.

Authors:  A H Groll; A Tragiannidis
Journal:  Clin Microbiol Infect       Date:  2010-09       Impact factor: 8.067

2.  Posaconazole plasma concentrations in juvenile patients with invasive fungal infection.

Authors:  Gopal Krishna; Angela Sansone-Parsons; Monika Martinho; Bhavna Kantesaria; Lisa Pedicone
Journal:  Antimicrob Agents Chemother       Date:  2007-01-08       Impact factor: 5.191

3.  Posaconazole salvage treatment in paediatric patients: a multicentre survey.

Authors:  T Lehrnbecher; A Attarbaschi; M Duerken; J Garbino; B Gruhn; U Kontny; S Lüer; R Phillips; J Scholz; H J Wagner; T Wiesel; A H Groll
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-05-22       Impact factor: 3.267
  3 in total
  9 in total

1.  Efficacy, safety and feasibility of antifungal prophylaxis with posaconazole tablet in paediatric patients after haematopoietic stem cell transplantation.

Authors:  Michaela Döring; Karin Melanie Cabanillas Stanchi; Manon Queudeville; Judith Feucht; Franziska Blaeschke; Patrick Schlegel; Tobias Feuchtinger; Peter Lang; Ingo Müller; Rupert Handgretinger; Werner J Heinz
Journal:  J Cancer Res Clin Oncol       Date:  2017-03-03       Impact factor: 4.553

Review 2.  Antifungal therapy in children: an update.

Authors:  Valerio Cecinati; Chiara Guastadisegni; Fabio Giovanni Russo; Letizia Pomponia Brescia
Journal:  Eur J Pediatr       Date:  2012-06-01       Impact factor: 3.183

3.  Antifungal agents in current pediatric practice.

Authors:  Cecinati Valerio; Teresa Perillo; Letizia Brescia; Fabio Giovanni Russo
Journal:  Curr Infect Dis Rep       Date:  2013-06       Impact factor: 3.725

4.  Current evidence of antifungal prophylaxis and therapy in pediatric patients.

Authors:  Mareva Giacchino; Giuseppe Maria Milano; Francesca Carraro; Stefania Bezzio; Anna Pegoraro; Franco Aversa; Simone Cesaro
Journal:  Pediatr Rep       Date:  2011-02-24

5.  Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia.

Authors:  M Döring; M Eikemeier; K M Cabanillas Stanchi; U Hartmann; M Ebinger; C-P Schwarze; A Schulz; R Handgretinger; I Müller
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-02-14       Impact factor: 3.267

6.  Comparison of itraconazole, voriconazole, and posaconazole as oral antifungal prophylaxis in pediatric patients following allogeneic hematopoietic stem cell transplantation.

Authors:  M Döring; O Blume; S Haufe; U Hartmann; A Kimmig; C-P Schwarze; P Lang; R Handgretinger; I Müller
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-10-31       Impact factor: 3.267

Review 7.  Advances in the Treatment of Mycoses in Pediatric Patients.

Authors:  Elias Iosifidis; Savvas Papachristou; Emmanuel Roilides
Journal:  J Fungi (Basel)       Date:  2018-10-11

8.  Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation.

Authors:  Michaela Döring; Carsten Müller; Pascal-David Johann; Annika Erbacher; Astrid Kimmig; Carl-Philipp Schwarze; Peter Lang; Rupert Handgretinger; Ingo Müller
Journal:  BMC Infect Dis       Date:  2012-10-19       Impact factor: 3.090

9.  Posaconazole as rescue therapy in African histoplasmosis.

Authors:  Daniel Gonçalves; Catarina Ferraz; Luisa Vaz
Journal:  Braz J Infect Dis       Date:  2013-01-09       Impact factor: 3.257
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.